deltatrials
Recruiting PHASE4 INTERVENTIONAL 2-arm NCT07397650

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure (FACILITATE-HF)

Sponsor: Juntendo University

Conditions Acute Heart Failure
Interventions Finerenone Oral Tablet Finerenone Placebo
Updated 1 time since 2026 Last updated: Feb 8, 2026 Started: Feb 28, 2026 Primary completion: Dec 31, 2027 Completion: Sep 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Acute Heart Failure, this trial is actively recruiting participants. The trial is conducted by Juntendo University and has accumulated 1 data snapshot since 2026. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

1 version recorded
Recruiting — PHASE4 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Juntendo University
Data source: Juntendo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Fukuoka, Japan , Handa, Japan , Iizuka, Japan , Izunokuni, Japan , Kakegawa, Japan , Kawagoe, Japan , Maebashi, Japan , Nagoya, Japan , Osaka, Japan , Sagamihara, Japan and 8 more locations